Diagnosis and Management of Persistent Pulmonary Arterio-venous Malformations following Embolotherapy

Chinmay Bhimaji Kulkarni; Patrik Sutphin; Shams Iqbal; Sanjeeva P. Kalva

doi:10.1016/j.acra.2022.08.012

Diagnosis and Management of Persistent Pulmonary Arterio-venous Malformations following Embolotherapy

Chinmay Bhimaji Kulkarni, Patrik Sutphin, Shams Iqbal, Sanjeeva P. Kalva

Research output: Contribution to journal › Review article › peer-review

1 Scopus citations

Abstract

Embolotherapy is the primary treatment for pulmonary arterio-venous malformations (PAVMs). Approximately, 2-25% of PAVMs demonstrate persistence following embolization. Early identification and treatment of persistent PAVMs are critical to mitigating life threatening complications. The presence of prior embolic devices and complex angioarchitecture of persistent PAVMs pose technical challenges during repeat embolotherapy. In this article, we review patterns of persistence, factors affecting the persistence, endovascular treatment techniques, and outcomes.

Original language	English (US)
Pages (from-to)	441-452
Number of pages	12
Journal	Academic radiology
Volume	30
Issue number	3
DOIs	https://doi.org/10.1016/j.acra.2022.08.012
State	Published - Mar 2023
Externally published	Yes

Keywords

Embolization
Hereditary Haemorrhagic telangiectasia (HHT)
Multidetector Computed Tomography
Pulmonary angiogram
Pulmonary arteriovenous malformation (PAVM)
Time-resolved Magnetic Resonance Angiography (TR-MRA)

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Access to Document

10.1016/j.acra.2022.08.012

Cite this

@article{1545ca8664704c89806bd0533daf2cab,

title = "Diagnosis and Management of Persistent Pulmonary Arterio-venous Malformations following Embolotherapy",

abstract = "Embolotherapy is the primary treatment for pulmonary arterio-venous malformations (PAVMs). Approximately, 2-25% of PAVMs demonstrate persistence following embolization. Early identification and treatment of persistent PAVMs are critical to mitigating life threatening complications. The presence of prior embolic devices and complex angioarchitecture of persistent PAVMs pose technical challenges during repeat embolotherapy. In this article, we review patterns of persistence, factors affecting the persistence, endovascular treatment techniques, and outcomes.",

keywords = "Embolization, Hereditary Haemorrhagic telangiectasia (HHT), Multidetector Computed Tomography, Pulmonary angiogram, Pulmonary arteriovenous malformation (PAVM), Time-resolved Magnetic Resonance Angiography (TR-MRA)",

author = "Kulkarni, {Chinmay Bhimaji} and Patrik Sutphin and Shams Iqbal and Kalva, {Sanjeeva P.}",

note = "Publisher Copyright: {\textcopyright} 2022 The Association of University Radiologists",

year = "2023",

month = mar,

doi = "10.1016/j.acra.2022.08.012",

language = "English (US)",

volume = "30",

pages = "441--452",

journal = "Academic radiology",

issn = "1076-6332",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - Diagnosis and Management of Persistent Pulmonary Arterio-venous Malformations following Embolotherapy

AU - Kulkarni, Chinmay Bhimaji

AU - Sutphin, Patrik

AU - Iqbal, Shams

AU - Kalva, Sanjeeva P.

PY - 2023/3

Y1 - 2023/3

N2 - Embolotherapy is the primary treatment for pulmonary arterio-venous malformations (PAVMs). Approximately, 2-25% of PAVMs demonstrate persistence following embolization. Early identification and treatment of persistent PAVMs are critical to mitigating life threatening complications. The presence of prior embolic devices and complex angioarchitecture of persistent PAVMs pose technical challenges during repeat embolotherapy. In this article, we review patterns of persistence, factors affecting the persistence, endovascular treatment techniques, and outcomes.

AB - Embolotherapy is the primary treatment for pulmonary arterio-venous malformations (PAVMs). Approximately, 2-25% of PAVMs demonstrate persistence following embolization. Early identification and treatment of persistent PAVMs are critical to mitigating life threatening complications. The presence of prior embolic devices and complex angioarchitecture of persistent PAVMs pose technical challenges during repeat embolotherapy. In this article, we review patterns of persistence, factors affecting the persistence, endovascular treatment techniques, and outcomes.

KW - Embolization

KW - Hereditary Haemorrhagic telangiectasia (HHT)

KW - Multidetector Computed Tomography

KW - Pulmonary angiogram

KW - Pulmonary arteriovenous malformation (PAVM)

KW - Time-resolved Magnetic Resonance Angiography (TR-MRA)

UR - http://www.scopus.com/inward/record.url?scp=85137720905&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85137720905&partnerID=8YFLogxK

U2 - 10.1016/j.acra.2022.08.012

DO - 10.1016/j.acra.2022.08.012

M3 - Review article

C2 - 36089478

AN - SCOPUS:85137720905

SN - 1076-6332

VL - 30

SP - 441

EP - 452

JO - Academic radiology

JF - Academic radiology

IS - 3

ER -

Diagnosis and Management of Persistent Pulmonary Arterio-venous Malformations following Embolotherapy

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this